These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6459932)

  • 21. Interaction of calmodulin with muscle phosphofructokinase. Interplay with metabolic effectors of the enzyme under physiological conditions.
    Mayr GW
    Eur J Biochem; 1984 Sep; 143(3):521-9. PubMed ID: 6236976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzyme concentration affects the allosteric behavior of yeast phosphofructokinase.
    Aragón JJ; Sánchez V
    Biochem Biophys Res Commun; 1985 Sep; 131(2):849-55. PubMed ID: 2932107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conformational modification of muscle phosphofructokinase from Jaculus orientalis upon ligand binding.
    Tijane M; el Hachimi Z; Benjouad A; Desmadril M; Yon JM
    FEBS Lett; 1989 Mar; 245(1-2):30-4. PubMed ID: 2522395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of 6-phosphofructo-1-kinase from a yeast mutant.
    Bigl M; Eschrich K; Hofmann E
    Biomed Biochim Acta; 1991; 50(3):239-50. PubMed ID: 1835381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the allosteric properties of rabbit muscle phosphofructokinase by means of affinity labeling with a reactive ATP analog.
    Nagata K; Suzuki K; Imahori K
    J Biochem; 1979 Nov; 86(5):1179-89. PubMed ID: 160416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heart phosphofructokinase. Allosteric kinetics following affinity labeling modification of the enzyme by 8-[m-(m-fluorosulfonylbenzamido) benzylthio] adenine.
    Mansour TE; Martensen TM
    J Biol Chem; 1978 May; 253(10):3628-34. PubMed ID: 148462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of muscle phosphofructokinase by alpha-glucose 1,6-bisphosphate and fructose 2,6-bisphosphate is differently affected by other allosteric effectors and by pH.
    Andrés V; Carreras J; Cussó R
    Biochem Biophys Res Commun; 1988 Dec; 157(2):664-9. PubMed ID: 2974284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of the AMP binding sites of rabbit phosphofructo-1-kinase isozymes B and C.
    Valaitis AP; Kwiatkowska D; Krishnaraj R; Kemp RG
    Biochim Biophys Acta; 1988 Oct; 956(3):232-42. PubMed ID: 2844270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification and properties of adductor muscle phosphofructokinase from the oyster, Crassostrea virginica. The aerobic/anaerobic transition: role of arginine phosphate in enzyme control.
    Storey KB
    Eur J Biochem; 1976 Nov; 70(2):331-7. PubMed ID: 12948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification and regulatory properties of phosphofructokinase from Trypanosoma (Trypanozoon) brucei brucei.
    Cronin CN; Tipton KF
    Biochem J; 1985 Apr; 227(1):113-24. PubMed ID: 3158309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetic modelling of yeast phosphofructokinase.
    Reuter R; Eschrich K; Schellenberger W; Hofmann E
    Acta Biol Med Ger; 1979; 38(8):1067-79. PubMed ID: 161131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The kinetics of effector binding to phosphofructokinase. The influence of effectors on the allosteric conformational transition.
    Roberts D; Kellett GL
    Biochem J; 1980 Sep; 189(3):569-79. PubMed ID: 6260084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of substrates and effectors on the reversible inactivation of pig spleen phosphofructokinase by adenosine triphosphate.
    Weidemann MJ; Kolbuch-Braddon ME; Hickman PE
    Biochem J; 1977 Sep; 165(3):525-37. PubMed ID: 21659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetic behaviour and regulatory properties of phosphofructokinase in rat bone marrow cells.
    Tejedor MC; Ramírez A; Luque J
    Biochem Int; 1984 Nov; 9(5):577-86. PubMed ID: 6098275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Affinity labeling of the allosteric site of fructose 1,6-bisphosphatase with an AMP analog.
    Sakai K; Kawashima S; Suzuki K; Imahori K
    J Biochem; 1987 Aug; 102(2):377-84. PubMed ID: 2822686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of liver 6-phosphofructokinase by fructose 2,6-bisphosphate and other effectors.
    Van Schaftingen E; Jett MF; Hue L; Hers HG
    Proc Natl Acad Sci U S A; 1981 Jun; 78(6):3483-6. PubMed ID: 6455662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effector-induced conformational transitions in Ascaris suum phosphofructokinase. A fluorescence and circular dichroism study.
    Rao GS; Cook PF; Harris BG
    J Biol Chem; 1991 May; 266(14):8884-90. PubMed ID: 1827437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Properties of phosphofructokinase from the mucosa of rat jejunum and their relation to the lack of Pasteur effect.
    Tejwani GA; Ramaiah A
    Biochem J; 1971 Nov; 125(2):507-14. PubMed ID: 4259410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of rat erythrocyte phosphofructokinase by AMP and by non-physiological concentrations of cyclic AMP.
    Pinilla M; Luque J
    Mol Cell Biochem; 1977 May; 15(3):219-23. PubMed ID: 196180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study on the initial kinetics of yeast phosphofructokinase by stopped-flow measurements.
    Bär J; Hübner G; Kopperschläger G
    Eur J Biochem; 1986 Apr; 156(2):311-5. PubMed ID: 2938948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.